Dmitry Balyasny’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Dmitry Balyasny’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-322,418	Closed	-$2.77M	–	3117
2023 Q1	$2.77M	Sell	322,418 -20,866	-6%	-$172K	0.01%	1330
2022 Q4	$2.96M	Sell	343,284 -19,254	-5%	-$155K	0.01%	1251
2022 Q3	$2.17M	Sell	362,538 -2,994	-0.8%	-$16.3K	0.01%	1446
2022 Q2	$1.97M	Buy	+365,532	New	+$1.97M	0.01%	1406

Other funds holding VECT

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dmitry Balyasny's VECT Position: Q2 2023 in Review

Dmitry Balyasny sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 322,418 shares — an estimated $2.77M sold.

Dmitry Balyasny first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $2.96M in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Dmitry Balyasny reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Dmitry Balyasny sold 322,418 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $2.77M.
Dmitry Balyasny first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
Dmitry Balyasny's VectivBio Holding AG Ordinary Shares position peaked at $2.96M in Q4 2022.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.